|

Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization

RECRUITINGSponsored by Seung-Jung Park
Actively Recruiting
SponsorSeung-Jung Park
Started2019-04-05
Est. completion2030-06
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03788369

Summary

This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.

Eligibility

Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 20 and more
* Hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery)
* Written consent

Exclusion Criteria:

* Previous CABG(coronary artery bypass graft)
* Life expectancy ≤1 year

Conditions5

Coronary Artery Bypass GraftingCoronary Artery Disease ProgressionCoronary StenosisHeart DiseasePercutaneous Coronary Revascularization

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.